Literature DB >> 8009561

Phenytoin age-dose-concentration relationship in children.

Y Suzuki1, T Mimaki, S Cox, J Koepke, J Hayes, P D Walson.   

Abstract

A list (n = 423) of phenytoin steady-state concentrations from children taking phenytoin alone or in combination with other drugs (n = 308) was obtained from our therapeutic drug monitoring database (1984-1990). Only 43% of concentrations were within the commonly accepted "therapeutic" or "reference" range (10-20 mg/L). Age-dose-concentration relationships showed that while occasional concentrations were above 20 mg/L, many patients receiving commonly recommended pediatric phenytoin doses (4-8 mg/kg/day) achieved concentrations below the reference range, especially children under 3 years of age. Michaelis-Menten pharmacokinetic parameters, maximal elimination rate (Vmax) and Michaelis constant (Km), were evaluated for patients with at least two steady-state concentrations measured for two or more different daily doses. Comedication with other drugs had no effect on either Vmax or Km for phenytoin. Vmax appeared to decrease significantly with age, but there was no age relationship for Km.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8009561     DOI: 10.1097/00007691-199404000-00006

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  4 in total

1.  Consequences of Phenytoin Exposure on Hepatic Cytochrome P450 Expression during Postnatal Liver Maturation in Mice.

Authors:  Stephanie C Piekos; Liming Chen; Pengcheng Wang; Jian Shi; Sharon Yaqoob; Hao-Jie Zhu; Xiaochao Ma; Xiao-Bo Zhong
Journal:  Drug Metab Dispos       Date:  2018-06-08       Impact factor: 3.922

2.  Clinical pharmacogenetics implementation consortium guidelines for CYP2C9 and HLA-B genotypes and phenytoin dosing.

Authors:  K E Caudle; A E Rettie; M Whirl-Carrillo; L H Smith; S Mintzer; M T M Lee; T E Klein; J T Callaghan
Journal:  Clin Pharmacol Ther       Date:  2014-08-06       Impact factor: 6.875

3.  Factors and Mechanisms for Pharmacokinetic Differences between Pediatric Population and Adults.

Authors:  Eva Fernandez; Raul Perez; Alfredo Hernandez; Pilar Tejada; Marta Arteta; Jose T Ramos
Journal:  Pharmaceutics       Date:  2011-02-07       Impact factor: 6.321

Review 4.  Neonatal pharmacology and clinical implications.

Authors:  Antonio Ruggiero; Anna Ariano; Silvia Triarico; Michele Antonio Capozza; Pietro Ferrara; Giorgio Attinà
Journal:  Drugs Context       Date:  2019-10-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.